1. The benefits and harms of breast cancer screening
Per-Henrik Zahl 
The Lancet 
Volume 381, Issue 9869, Pages (March 2013)
DOI: /S (13)
Copyright © 2013 Elsevier Ltd Terms and Conditions

2. Figure
Incidence of invasive breast cancer and ductal carcinoma in situ in women aged 50 69 years in Norway invited to prevalence screening in 1996 97 and women older than 69 years who are no longer invited to screening
Vertical lines indicate years with prevalence screening.
The Lancet  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions